Retinopathy of Prematurity Market - Top Companies and Manufacturers

  • Report ID: 5823
  • Published Date: Mar 05, 2024
  • Report Format: PDF, PPT

Companies Dominating the Retinopathy of Prematurity Landscape

    • Visunex Medical System
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merge Healthcare
    • Natus Medical Incorporated
    • Servicom Medical
    • Advancing Eyecare
    • Insmed Inc
    • Alimera Sciences Inc.
    • Biomar Microbial Technologies
    • Regeneron Pharmaceuticals
    • Hoffmann-La-Rochelnc

Browse Key Market Insights with Data Illustration:

In the News

  • January 2023: Natus Medical Incorporated, a leading provider of medical device solutions announced the closing of its acquisition of micromed holding SAS, a global provider of neurophysiology solution. Micromed products will be added to Natus neuro portfolio and developed alongside Natus technologies. The newly merged organization brings together innovative neurodiagnostic solutions and experienced team to offer a broader portfolio of products, services and support to customer worldwide. In addition, The Natus legacy of over 85 years of neurodiagnostic leadership will grow through the addition of the complete line of micromed solutions to comprise an even stronger portfolio of products across polysomnography and intensive care unit monitoring. 
  • November 2022: Advancing Eyecare, North America leading provider of ophthalmic instruments, announced that acquisition of Veatch Ophthalmic Instruments which is a leading U.S. distributor of ophthalmic equipment. Veatch has more than 30 years history of distributing ophthalmic technology to vision care providers throughout the US. Veatch and Advancing Eyecare, with a shared commitment to best-in-class customer support will expand product and services offering to their combined customers and capitalize on synergistic growth opportunities. In addition, AEC partnered with Cornell Capital, a US based private firm to drive growth, expand the company’s reach and further enhances AEC’s ability to provide high quality , innovative products and services to a growing customer base.

Author Credits:  Radhika Pawar


  • Report ID: 5823
  • Published Date: Mar 05, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising expenditure on healthcare, adoption of telemedicine and collaborations & partnerships among healthcare institutions and research organizations are the major factors driving the growth of the retinopathy of prematurity market.

The market size of retinopathy of prematurity is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2024-2036.

The major players in the market are Merge Healthcare, Insmed Inc, Advancing Eyecare, Natus Medical Incorporated and others.

The Partial Retinal Detachment segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample